Pál B.
- Country
- Hungary
- Department
- Belgyógyászati Osztály
Research Overview
- Evaluation of Baxdrostat and Dapagliflozin on Chronic Kidney Disease Progression in Hypertensive Patients: A Randomized, Double-Blind, Active-Controlled Phase III Trial
- Efficacy and Safety of Cagrilintide and Semaglutide in Patients with Type 2 Diabetes, Chronic Kidney Disease, and Overweight or Obesity
Data & Insights
Has run more than one trial at 9 of 194 partner sites.
Specializations
Chronic Kidney Disease and Hypertension
Pál Brasnyó is involved in clinical research focused on slowing the progression of chronic kidney disease in adults with high blood pressure, with attention to kidney function and long-term renal protection.
- eGFR preservation
- CKD progression
- Hypertensive kidney disease
His work in this area reflects a therapeutic interest in kidney-focused interventions for patients managed through the Belgyógyászati Osztály at Siofoki Korhaz-Rendelointezet.
Type 2 Diabetes and Metabolic Kidney Protection
His research landscape includes studies in type 2 diabetes with overweight or obesity, centered on reducing kidney damage and improving surrogate markers linked to renal decline.
- Diabetic kidney disease
- Obesity-related metabolic risk
- Renal protection in diabetes
This therapeutic domain connects metabolic disease management with prevention of further kidney impairment.
Severe Chronic Rhinosinusitis with Nasal Polyps and Asthma
Pál Brasnyó is also engaged in respiratory and upper-airway inflammation research for patients with severe CRSwNP and coexisting asthma, with emphasis on reducing nasal polyp burden and improving nasal obstruction.
- Eosinophilic airway inflammation
- Nasal polyp burden
- Asthma-associated sinonasal disease
This area highlights therapeutic interest in controlling chronic inflammatory disease affecting both the upper and lower airways.
Acute Respiratory Distress Syndrome due to Infection
His clinical trial activity includes critical care research in acute respiratory distress syndrome caused by pneumonia or other infections, with focus on treatment options for severe respiratory failure.
- Infection-related ARDS
- Severe respiratory insufficiency
- Critical care therapeutics
This domain places his work at the intersection of pulmonary medicine and intensive care treatment innovation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.